INTERVIEW: Ally Bridge CEO On De-Risking China And Investing In 2016
This article was originally published in PharmAsia News
With $1bn under management, the Hong Kong private equity firm Ally Bridge Group bagged multiple deals in 2015 including WuXi's $3.3bn privatization. CEO Frank Yu spoke to PharmAsia News about pursuing a holistic approach that goes beyond its China roots.
Register for our free email digests: